Executive Team
Dr. Li is an imaging scientist and an entrepreneur, with a proven record of innovation touching the lives of thousands of patients and researchers.
Dr. Li’s first invention in 2017 was licensed to Bruker Instruments and became the foundational patent for Photothermal Spectroscopy Corps. The product enabled by Dr. Li’s invention is now serving 100+ universities and industry leaders.
Dr. Li’s second invention in 2020 became the foundation of Cision Vision. Within three short years, Dr. Li led Cision Vision to transform a scientific concept to a commercial clinical product that is currently serving top cancer care institutions across the country, including 5 of the top 10 US News Best Oncology Hospitals.
Jeremy Li, Ph.D.
Dr. Angela Belcher is a world-renowned scientist at MIT. Between 2019 – 2023, she served as the Head of the Bioengineering Department at MIT. She is a member of the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Inventors. She is also a 2019 MacArthur Fellow.
Dr. Belcher is a visionary who saw the potential of shortwave infrared for biomedical application far ahead its time when it was still strictly limited by the military. Cision’s technology is built on Dr. Belcher’s 10+ years of cutting-edge research on biomedical shortwave infrared imaging.
Angela Belcher, Ph.D.
Mike Wallace is a medtech serial entrepreneur and innovation leader. He was the CEO and Co-Founder of DeVoro Medical. DeVoro’s innovative non-console and lytic-free WOLF technology targets and rapidly captures blood clots using finger-like prongs that retrieve and remove thrombi in the arterial and venous systems. DeVoro was acquired by Boston Scientific for $400 million dollars in 2022.
Prior to DeVoro, Mike advanced care in the neurovascular space through various leadership roles. He was the Chief Technical Officer and VP of Operations for Silk Road Medical (acquired by Boston Scientific Corporation). He co-founded three other startups and brought the technologies to be adopted in the real-world: TW Medical and GW Medical Neuro (both acquired by Stryker Corp) and CardioProlific (acquired by Philips). He currently holds positions as Venture Partner in ShangBay Capital and co-founder of women’s health company KoKoMedical.
Mike Wallace
John is an ASCP board-certified Pathologists’ Assistant and the visionary founder of two companies at the forefront of advancing pathology technologies, accelerating clinical trials, and driving life science research. He has been instrumental in achieving commercial success and market penetration for groundbreaking technologies focused on transforming human health and scientific discovery.
His ability to navigate complex markets, coupled with his deep commitment to advancing pathology, underscores his impact as a forward-thinking CCO dedicated to shaping the future of healthcare. John’s background also spans over 20 years in technical, faculty, and leadership roles across government, academic, and community healthcare sectors.
John Manuel, PA(ASCP)
Hern brings 18 years of experience in guiding companies through full product life cycles of a wide range of Class I/II/III medical devices. Optimizing functionality and ergonomics for operational safety while developing market appropriate aesthetics for manufacturing is the value that Hern brings to all programs. His experience stems mainly from dental equipment, medical handheld devices and carts, catheter delivery systems, and medical wearables. Hern’s work in medical devices has won multiple awards including the MDEA, Red Dot, and Edison awards.
At Cision, Hern is leading product development and rapid prototyping. Hern is one of the key contributors to Cision’s 2023 Red Dot Design Award.
Hern Kim
David has over 16 years of experience in QMS project management, GxP compliance, and QC analytical benchwork. He has implemented and maintained international regulatory standards such as ISO 9001, ISO 13485, and ISO 17025 for multiple pharmaceutical, biotech, and medical device companies.
At Cision, David developed the company’s QMS system, managed ISO 13485 certification and audits, and FDA registration and submissions.
David Wilkerson
Business Advisory Board
`Jay is the President Emeritus and Co-Founder of Hologic. He started Hologic with his co-founder, David Ellenbogen, with a dozen employees. Throughout his tenure at Hologic, Jay grew the company to one of the biggest medtech companies in the world with a market cap of more than $17 billion.
Jay has been a close mentor to the Cision Vision team, even prior to the incorporation of the company. His relentless focus on patient care and doing good, which ultimately led to the success of Hologic, has also become a core value at Cision Vision.
Jay is the consulting Chief Financial Officer for Siesta Medical. He has worked as a consulting CFO for development-phase biotechnology and medical device companies for more than 25 years. Jay has helped raise and manage over $1.5 billion to fund early-stage companies. His clients have included, Millennium Pharmaceuticals, CV Therapeutics, Prograft Medical, Spinal Kinetics, Millipede, Sutro Biopharma, Vaxcyte, Simplify Medical and PMV Pharma.
Prior to his consulting work, Jay was the Controller at Neurex Corporation. He also held successive financial management positions at Genentech and was a managing consultant at Andersen Consulting, the predecessor firm to Accenture. Jay served on active duty in the US Army Corps of Engineers and is Airborne and Ranger qualified.
Carl is Principal at CD Global Consulting, a firm with expertise in assessing and formulating strategic marketing plans, developing value proposition, designing effective Go-To-Market strategies, and contract negotiation. Prior to CD Global, he was Vice President, Medical Devices at ChemImage, a leader in advanced imaging and machine learning technology, in addition to EOS Imaging, which produces whole body images of a standing patient in a single scan, and frontal and lateral digital images for the use of radiologists, orthopedic surgeons and rheumatologists.
Carl has comprehensive expertise in the global medical industry with skills spanning from marketing, commercialization, business development, and sales operations. He has shaped industry trajectories, championing a customer-centric culture rooted in value and accountability in complex multicultural settings.
Kate is a seasoned corporate executive with deep experience serving as board members and trustees for technology companies and large organizations, including Baystate Health.
Kate advises the Cision team on customer discovery, product commercialization, and financial planning.
Tico is Vice President of Product at Eko Health, a digital health company advancing how healthcare professionals detect and monitor heart and lunch disease. He leads product innovation and strategy for transforming cardiopulmonary care with AI and cloud computing. With over 20 years of experience in healthcare product leadership, he has launched impactful solutions across services, software, implantable and wearable devices that have improved patient outcomes and user experiences worldwide.
Prior to Eko, he served as head of product management for Ion, Intuitive’s robotic-assisted platform for minimally invasive biopsy in the lung. Before Intuitive, Blumenthal held leadership positions at Cordis, Dock Technologies, and Medtronic, including as a co-founder of Medtronic’s Shanghai Innovation Center.
Medical Advisory Board
Trained as a surgeon and a bioengineer, Alfred has industry experience as a leader of a matrix organization of product managers, medical science liaisons, and ML clinical engineers. He is an AI/ML/Data specialist within health tech and specifically surgical robotics.
After completing his Biodesign Innovation Fellowship and during surgical residency at Stanford Medicine, Alfred joined Intuitive as Director of Digital Product Management, Clinical Intelligence, and Medical Sciences. He led a group of product managers, medical science managers, and digital clinical engineers to solve problems in the field of digital surgery.
James is board certified in anatomical and clinical pathology and has an extensive background in both medicine and healthcare management. He trained at the prestigious Columbia University Vagelos College of Physicians and Surgeons and completed his residency at NewYork-Presbyterian/Columbia and the University of Southern California/Los Angeles General Medical Center.
Throughout his distinguished career, James has served in pivotal roles such as Director of Laboratory and Chief of Staff at Pomona Valley Hospital Medical Center and dual-appointment as Medical Director of Pathology and Chief of Staff at St. Dominic Hospital. Before his tenure at LabCorp, James made significant contributions as a Medical Officer at CMS and as the Medical Director of MolDX (Palmetto GBA), one of the nation’s largest Medicare administrators.
Mary is the Chair and Program Director for the Pathologists’ Assistant (PA) Department at Rosalind Franklin University (RFU), the biggest PA program in the United States. Over the 11 years that Mary as an anatomic pathology educator at RFU, Mary has trained more than 300 PAs who are now serving patients in hospitals across the country.
At Cision, Mary is utilizing her medical expertise to ensure that Cision’s product provides the optimal usability to pathology practitioners and maximum clinical benefits to patients. Mary has been involved in 5 iterations of InVision’s development process and is also currently involved in Cision’s R&D process for future products.
Matthew is an academic researcher at Beth Israel Deaconess Medical Center and an assistant professor at Harvard School of Medicine. He practices anatomic and clinical pathology.
Matthew has published 25 research articles with 700+ citations on a variety of topics, including cytodiagnosis, next generational sequencing, and immunohistochemistry as predictive and prognostic markers.
Sihem is an independent pathologist who consults for multiple biotech companies, including AstraZeneca, Roche Diagnostics, and CDx at Ventana Medical Systems. She conducts research on cancer immunochemistry and pathology and has expertise in patient safety. Her recent projects include helping to apply computational pathology solutions to support early and late-stage clinical drug development.
Most recently, Sihem was the Senior Director of Computational Pathology at AstraZeneca in Munich, Germany before moving to Indiana in the US. Among other roles, she was the Foreign Director of Breast Cancer Center in Wenzhou, China and Assistant Professor of Pathology at Yale School of Medicine in New Haven, Connecticut.
Yuanzhi is an Assistant Professor in the Department of Neurosurgery at Stanford Medicine, along with his role as the co-director of the Stanford Neurosurgical Training and Innovation Center in China. Prior to Stanford, he was at Huashan Hospital, Fudan University in China.
With training in neurosurgery, Yuanzhi is a trailblazer in brain tumor research, microsurgical anatomic innovation, and integration of AR/VR technology into brain surgeries. He has published more than 65 peer-reviewed articles that have been cited 370+ times. Yuanzhi’s extensive expertise underscores his role as a distinguished thought leader in these innovative fields and will contribute significantly to Cision Vision’s efforts.
Randall is the Laboratory Medical Director at Pathology Associates of Central Mississippi, LLC. He and his team analyze biopsied tissue or bodily fluids, and interpret medical tests, including tests done by other specialists like dermatologists, cardiologists, and oncologists. Randall received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice for more than 30 years.
Our Mission
Our mission is to develop medical innovations that address real-world healthcare challenges, informed by clinicians from multiple disciplines. When we develop new technologies to improve disease diagnosis, enhance surgical procedures, and reduce complications, we prioritize receiving input from the people who are most impacted by the decisions we make—the individuals whose health outcomes rely on how effective the devices we build are and the clinicians who use our devices. With their partnership and input, we aim to breakthrough current barriers to improve health outcomes for millions of people in need around the world.
Visionary Program
Ready to Book a Demo?
